Search Results 41-50 of 16307 for Chronic Lymphocytic Leukemia

  1. A Study to Compare ACP-196 and Obinutuzumab with Chlorambucil, or ACP-19 alone, with Obinutuzumab and Chlorambucil, for Patients with Previously Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

    ... chronic lymphocytic leukemia (CLL). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  2. Chronic Lymphoproliferative Disorders Group - Overview - Mayo Clinic

    Chronic lymphocytic leukemia · Hairy cell leukemia; Large granular lymphocyte disorders; Lymphocytosis; Natural killer cell leukemia; Prolymphocytic leukemia.

  3. A Study to Evaluate Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

    ... chronic lymphocytic leukemia. Ibrutinib may stop the growth of cancer cells ... Giving ibrutinib and obinutuzumab with venetoclax may work better at treating ...

  4. A Study to Evaluate the Safety and Tolerability of KTE-X19 in Adults with Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma - Mayo Clinic

    ... chronic lymphocytic leukemia (r/r CLL) and Small Lymphocytic Lymphoma (r/r SLL). Participation eligibility. Participant eligibility includes age, gender ...

  5. Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small ...

  6. A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma.

  7. Study of BMF-219, in Adult Patients With Acute Leukemia (AL), Diffuse Large B-cell Lymphoma (DLBCL), Multiple Myeloma (MM), and Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

    Study of BMF-219, in Adult Patients With Acute Leukemia (AL), Diffuse Large B-cell Lymphoma (DLBCL), Multiple Myeloma (MM), and Chronic Lymphocytic Leukemia ...

  8. Lenalidomide and AT-101 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia - Mayo Clinic

    ... chronic lymphocytic leukemia (B-CLL). Biological therapies, such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells ...

  9. A Study to Define Axl Expression Level in Skin Biopsy Specimens from Patients with Skin Cancer in Relation to Chronic Lymphocytic Leukemia - Mayo Clinic

    ... Chronic Lymphocytic Leukemia. Print details. Share; Facebook · Twitter. Overview ... Diagnosis of Skin Cancer, with or without a CLL diagnosis. Exclusion ...

  10. A Study Comparing Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

    ... chronic lymphocytic leukemia. Ibrutinib may stop the growth of cancer cells ... Giving ibrutinib, obinutuzumab and venetoclax may work better in treating patients ...